Werbung
Werbung

CTXR

CTXR logo

Citius Pharmaceuticals Inc. Common

0.88
USD
Gesponsert
-0.02
-2.56%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

0.87

-0.01
-0.80%

CTXR Ergebnisberichte

Positives Überraschungsverhältnis

CTXR übertreffen die 9 der letzten 26Schätzungen.

35%

Nächster Bericht

Datum des nächsten Berichts
12. Feb. 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.52M
/
-$0.01
Implizierte Änderung von Q4 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q1 25 (Revenue/ EPS)
--
/
-99.23%

Citius Pharmaceuticals Inc. Common earnings per share and revenue

On 26. Dez. 2025, CTXR reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.49 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 5.87 million, with a -100.00% difference. The market reacted with a -1.69% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 3.52 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q4 2025, Citius Pharmaceuticals Inc. Common reported EPS of --, missing estimates by --, and revenue of $0.00, -100% below expectations.
The stock price moved down -1.69%, changed from $0.84 before the earnings release to $0.83 the day after.
The next earning report is scheduled for 12. Feb. 2026.
Based on 3 analysts, Citius Pharmaceuticals Inc. Common is expected to report EPS of -$0.01 and revenue of $3.52M for Q1 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung